Uses and Challenges of Antiviral Polyclonal and Monoclonal Antibody Therapies
Viral diseases represent a major public health concerns and ever-present risks for developing into future pandemics. Antiviral antibody therapeutics, either alone or in combination with other therapies, emerged as valuable preventative and treatment options, including during global emergencies. Here...
Saved in:
Main Authors: | Evi B. Struble (Author), Jonathan M. O. Rawson (Author), Tzanko Stantchev (Author), Dorothy Scott (Author), Marjorie A. Shapiro (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antibody immunoprophylaxis and immunotherapy for influenza virus infection: Utilization of monoclonal or polyclonal antibodies?
by: Cassandra M. Berry
Published: (2018) -
Impact of SARS-CoV-2 Resistance to Antiviral Monoclonal Antibody Therapy on Neutralizing Antibody Response
by: Marc-Kendy Paul, et al.
Published: (2024) -
Generation and application of monoclonal and polyclonal antibodies against hemagglutinin of H7N9 avian influenza virus
by: Yi-Wei Hong, et al.
Published: (2016) -
Comparison of the C-mediating killing activity and C-activating properties of mouse monoclonal and polyclonal antibodies against Trypanosoma cruzi
by: T. L. Kipnis, et al.
Published: (1992) -
Analysis of epitopes on dengue virus envelope protein recognized by monoclonal antibodies and polyclonal human sera by a high throughput assay.
by: Hong-En Lin, et al.
Published: (2012)